+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alimta"

Alimta - Product Thumbnail Image

Alimta

  • Report
  • August 2018
  • 27 Pages
  • Global
From
alimta - API Insight, 2022 - Product Thumbnail Image

alimta - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
alimta- Drug Insight, 2019 - Product Thumbnail Image

alimta- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Alimta is a chemotherapy drug used to treat non-small cell lung cancer (NSCLC). It is a platinum-based drug, meaning it contains a platinum atom in its chemical structure. Alimta is used in combination with other drugs to treat NSCLC, and is often used in combination with cisplatin. Alimta is also used to treat mesothelioma, a type of cancer caused by exposure to asbestos. Alimta is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2004. Since then, it has become a popular treatment for NSCLC and mesothelioma. Alimta is marketed by Eli Lilly and Company, and is available in both generic and brand-name versions. Other companies that produce Alimta include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more